Top compounds associated with response to ESRRG


Feature Type Standardized
Nominal ANOVA
mRNA RAF265 CTRPv2 pan-cancer AAC 0.21 3e-07
mRNA Docetaxel GDSC1000 pan-cancer AAC -0.17 4e-07
mRNA GW-405833 CTRPv2 pan-cancer AAC 0.17 5e-07
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.18 6e-07
mRNA navitoclax:piperlongumine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.18 8e-07
mRNA FK866 GDSC1000 pan-cancer AAC 0.16 9e-07
mRNA decitabine:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.15 9e-07
mRNA BIBR-1532 CTRPv2 pan-cancer AAC 0.18 1e-06
mRNA PX-12 CTRPv2 pan-cancer AAC 0.14 1e-06
mRNA indisulam CTRPv2 pan-cancer AAC 0.16 1e-06
Download CSV